195 related articles for article (PubMed ID: 34992539)
1. Lacosamide Inhibition of Na
Labau JIR; Alsaloum M; Estacion M; Tanaka B; Dib-Hajj FB; Lauria G; Smeets HJM; Faber CG; Dib-Hajj S; Waxman SG
Front Pharmacol; 2021; 12():791740. PubMed ID: 34992539
[TBL] [Abstract][Full Text] [Related]
2. Lidocaine Binding Enhances Inhibition of Nav1.7 Channels by the Sulfonamide PF-05089771.
Jo S; Bean BP
Mol Pharmacol; 2020 Jun; 97(6):377-383. PubMed ID: 32193331
[TBL] [Abstract][Full Text] [Related]
3. Lacosamide Inhibition of Nav1.7 Voltage-Gated Sodium Channels: Slow Binding to Fast-Inactivated States.
Jo S; Bean BP
Mol Pharmacol; 2017 Apr; 91(4):277-286. PubMed ID: 28119481
[TBL] [Abstract][Full Text] [Related]
4. Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
Labau JIR; Estacion M; Tanaka BS; de Greef BTA; Hoeijmakers JGJ; Geerts M; Gerrits MM; Smeets HJM; Faber CG; Merkies ISJ; Lauria G; Dib-Hajj SD; Waxman SG
Brain; 2020 Mar; 143(3):771-782. PubMed ID: 32011655
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of voltage-gated Na⁺ channels by the synthetic cannabinoid ajulemic acid.
Foadi N; Berger C; Pilawski I; Stoetzer C; Karst M; Haeseler G; Wegner F; Leffler A; Ahrens J
Anesth Analg; 2014 Jun; 118(6):1238-45. PubMed ID: 24755846
[TBL] [Abstract][Full Text] [Related]
6. A Nav1.7 channel mutation associated with hereditary erythromelalgia contributes to neuronal hyperexcitability and displays reduced lidocaine sensitivity.
Sheets PL; Jackson JO; Waxman SG; Dib-Hajj SD; Cummins TR
J Physiol; 2007 Jun; 581(Pt 3):1019-31. PubMed ID: 17430993
[TBL] [Abstract][Full Text] [Related]
7. Voltage sensor interaction site for selective small molecule inhibitors of voltage-gated sodium channels.
McCormack K; Santos S; Chapman ML; Krafte DS; Marron BE; West CW; Krambis MJ; Antonio BM; Zellmer SG; Printzenhoff D; Padilla KM; Lin Z; Wagoner PK; Swain NA; Stupple PA; de Groot M; Butt RP; Castle NA
Proc Natl Acad Sci U S A; 2013 Jul; 110(29):E2724-32. PubMed ID: 23818614
[TBL] [Abstract][Full Text] [Related]
8. The Selective Nav1.7 Inhibitor, PF-05089771, Interacts Equivalently with Fast and Slow Inactivated Nav1.7 Channels.
Theile JW; Fuller MD; Chapman ML
Mol Pharmacol; 2016 Nov; 90(5):540-548. PubMed ID: 27587537
[TBL] [Abstract][Full Text] [Related]
9. Block of human cardiac sodium channels by lacosamide: evidence for slow drug binding along the activation pathway.
Wang GK; Wang SY
Mol Pharmacol; 2014 May; 85(5):692-702. PubMed ID: 24563546
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of Nav1.7 channels by methyl eugenol as a mechanism underlying its antinociceptive and anesthetic actions.
Wang ZJ; Tabakoff B; Levinson SR; Heinbockel T
Acta Pharmacol Sin; 2015 Jul; 36(7):791-9. PubMed ID: 26051112
[TBL] [Abstract][Full Text] [Related]
11. Differential modulation of Nav1.7 and Nav1.8 peripheral nerve sodium channels by the local anesthetic lidocaine.
Chevrier P; Vijayaragavan K; Chahine M
Br J Pharmacol; 2004 Jun; 142(3):576-84. PubMed ID: 15148257
[TBL] [Abstract][Full Text] [Related]
12. A thermosensitive mutation alters the effects of lacosamide on slow inactivation in neuronal voltage-gated sodium channels, NaV1.2.
Abdelsayed M; Sokolov S; Ruben PC
Front Pharmacol; 2013; 4():121. PubMed ID: 24065921
[TBL] [Abstract][Full Text] [Related]
13. Fast-onset lidocaine block of rat NaV1.4 channels suggests involvement of a second high-affinity open state.
Gingrich KJ; Wagner LE
Biochim Biophys Acta; 2016 Jun; 1858(6):1175-88. PubMed ID: 26922882
[TBL] [Abstract][Full Text] [Related]
14. State- and use-dependent block of muscle Nav1.4 and neuronal Nav1.7 voltage-gated Na+ channel isoforms by ranolazine.
Wang GK; Calderon J; Wang SY
Mol Pharmacol; 2008 Mar; 73(3):940-8. PubMed ID: 18079277
[TBL] [Abstract][Full Text] [Related]
15. Differential block of sensory neuronal voltage-gated sodium channels by lacosamide [(2R)-2-(acetylamino)-N-benzyl-3-methoxypropanamide], lidocaine, and carbamazepine.
Sheets PL; Heers C; Stoehr T; Cummins TR
J Pharmacol Exp Ther; 2008 Jul; 326(1):89-99. PubMed ID: 18378801
[TBL] [Abstract][Full Text] [Related]
16. Structure and function of hainantoxin-III, a selective antagonist of neuronal tetrodotoxin-sensitive voltage-gated sodium channels isolated from the Chinese bird spider Ornithoctonus hainana.
Liu Z; Cai T; Zhu Q; Deng M; Li J; Zhou X; Zhang F; Li D; Li J; Liu Y; Hu W; Liang S
J Biol Chem; 2013 Jul; 288(28):20392-403. PubMed ID: 23703613
[TBL] [Abstract][Full Text] [Related]
17. Differences in local anaesthetic and antiepileptic binding in the inactivated state of human sodium channel Nav1.4.
Buyan A; Whitfield AA; Corry B
Biophys J; 2021 Dec; 120(24):5553-5563. PubMed ID: 34774501
[TBL] [Abstract][Full Text] [Related]
18. Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.
de Greef BT; Merkies IS; Geerts M; Faber CG; Hoeijmakers JG
Trials; 2016 Jun; 17(1):306. PubMed ID: 27363506
[TBL] [Abstract][Full Text] [Related]
19. Local anesthetic-like inhibition of voltage-gated Na(+) channels by the partial μ-opioid receptor agonist buprenorphine.
Leffler A; Frank G; Kistner K; Niedermirtl F; Koppert W; Reeh PW; Nau C
Anesthesiology; 2012 Jun; 116(6):1335-46. PubMed ID: 22504149
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of neuronal Na
Peng YS; Wu HT; Lai YC; Chen JL; Yang YC; Kuo CC
Neuropharmacology; 2020 Nov; 179():108266. PubMed ID: 32853658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
